Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 11.032% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. CC(=O)Nc1nnc(SCc2ccc(C(=O)Nc3ccccc3F)cc2)s1
b. Cc1ccc(NS(=O)(=O)c2ccc(CCC(=O)N3CCCC3)cc2)cc1
c. Cn1c(=O)c([N+](=O)[O-])c(NC2CCS(=O)(=O)C2)c2ccccc21
d. CCc1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=S)NC)cc1
e. O=C(Cn1nnc2ccccc2c1=O)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1
Answer: b. Cc1ccc(NS(=O)(=O)c2ccc(CCC(=O)N3CCCC3)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NS(=O)(=O)c2ccc(CCC(=O)N3CCCC3)cc2)cc1
Cc1ccc(NS(=O)(=O)c2ccc(CCC(=O)N3CCCC3)cc2)cc1
N-(4-methylphenyl)-4-(3-oxo-3-pyrrolidin-1-ylpropyl)benzenesulfonamide